Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 9/2018

01-07-2018 | Short Communication

18F-FDG PET and high-resolution MRI co-registration for pre-surgical evaluation of patients with conventional MRI-negative refractory extra-temporal lobe epilepsy

Authors: Yao Ding, Yuankai Zhu, Biao Jiang, Yongji Zhou, Bo Jin, Haifeng Hou, Shuang Wu, Junming Zhu, Zhong Irene Wang, Chong H. Wong, Meiping Ding, Hong Zhang, Shuang Wang, Mei Tian

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 9/2018

Login to get access

Abstract

Purpose

Epilepsy that originates outside of the temporal lobe can present some of the most challenging problems for surgical therapy, especially for patients with conventional magnetic resonance imaging (MRI)-negative refractory extra-temporal lobe epilepsy (ETLE). This study aimed to evaluate the clinical value of pre-surgical 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG PET) and high-resolution MRI (HR-MRI) co-registration in patients with conventional MRI-negative refractory ETLE, and compare their surgical outcomes.

Methods

Sixty-seven patients with conventional MRI-negative refractory ETLE were prospectively included for pre-surgical 18F-FDG PET and HR-MRI examinations. Under the guidance of 18F-FDG PET and HR-MRI co-registration, HR-MRI images were re-read. Based on the image result changes from first reading to re-reading, patients were divided into three groups: Change-1 (lesions of subtle abnormality could be identified in re-read), Change-2 (non-specific abnormalities reported in the first reading were considered as lesions on HR-MRI re-read) and No-change. Post-surgical follow-ups were conducted for up to 59 months.

Results

Visual analysis of 18F-FDG PET showed focal or regional abnormality in 46 patients (68.6%), while the abnormal rate increased to 94.0% (P < 0.05) by co-registration. Of the 67 patients, 46.3% of them were identified as Change-1, and 11.9% as Change-2 after co-registration and HR-MRI re-read. Patients with Change-1 and -2 were more likely to be recommended to receive surgical resection (P < 0.001). In the 17 post-surgical patients, 88% had good outcomes, whereas 11.7% had poor outcomes during our study period.

Conclusion

Pre-surgical evaluation by co-registration of 18F-FDG PET and HR-MRI could improve the identification of the epileptogenic onset zone (EOZ), and may further guide the surgical decision-making and improve the outcome of the refractory ETLE with normal conventional MRI; therefore, it should be recommended as a standard procedure for pre-surgical evaluation of these patients.
Literature
1.
go back to reference Jette N, Sander JW, Keezer MR. Surgical treatment for epilepsy: the potential gap between evidence and practice. Lancet Neurol. 2016;15:982–94.CrossRefPubMed Jette N, Sander JW, Keezer MR. Surgical treatment for epilepsy: the potential gap between evidence and practice. Lancet Neurol. 2016;15:982–94.CrossRefPubMed
2.
go back to reference Blount JP. Extratemporal resections in pediatric epilepsy surgery-an overview. Epilepsia. 2017;58:19–27.CrossRefPubMed Blount JP. Extratemporal resections in pediatric epilepsy surgery-an overview. Epilepsia. 2017;58:19–27.CrossRefPubMed
3.
go back to reference Muhlhofer W, Tan YL, Mueller SG, Knowlton R. MRI-negative temporal lobe epilepsy-what do we know? Epilepsia. 2017;58:727–42.CrossRefPubMed Muhlhofer W, Tan YL, Mueller SG, Knowlton R. MRI-negative temporal lobe epilepsy-what do we know? Epilepsia. 2017;58:727–42.CrossRefPubMed
4.
go back to reference Jones AL, Cascino GD. Evidence on use of neuroimaging for surgical treatment of temporal lobe epilepsy: a systematic review. JAMA Neurol. 2016;73:464–70.CrossRefPubMed Jones AL, Cascino GD. Evidence on use of neuroimaging for surgical treatment of temporal lobe epilepsy: a systematic review. JAMA Neurol. 2016;73:464–70.CrossRefPubMed
5.
go back to reference Yang PF, Pei JS, Zhang HJ, Lin Q, Mei Z, Zhong ZH, et al. Long-term epilepsy surgery outcomes in patients with PET-positive, MRI-negative temporal lobe epilepsy. Epilepsy Behav. 2014;41:91–7.CrossRefPubMed Yang PF, Pei JS, Zhang HJ, Lin Q, Mei Z, Zhong ZH, et al. Long-term epilepsy surgery outcomes in patients with PET-positive, MRI-negative temporal lobe epilepsy. Epilepsy Behav. 2014;41:91–7.CrossRefPubMed
6.
go back to reference West S, Nolan SJ, Newton R. Surgery for epilepsy: a systematic review of current evidence. Epileptic Dis. 2016;18:113–21. West S, Nolan SJ, Newton R. Surgery for epilepsy: a systematic review of current evidence. Epileptic Dis. 2016;18:113–21.
7.
go back to reference Drzezga A, Arnold S, Minoshima S, Noachtar S, Szecsi J, Winkler P, et al. 18F-FDG PET studies in patients with extratemporal and temporal epilepsy: evaluation of an observer-independent analysis. J Nucl Med. 1999;40:737–46.PubMed Drzezga A, Arnold S, Minoshima S, Noachtar S, Szecsi J, Winkler P, et al. 18F-FDG PET studies in patients with extratemporal and temporal epilepsy: evaluation of an observer-independent analysis. J Nucl Med. 1999;40:737–46.PubMed
8.
go back to reference Harvey AS, Mandelstam SA, Maixner WJ, Leventer RJ, Semmelroch M, MacGregor D, et al. The surgically remediable syndrome of epilepsy associated with bottom-of-sulcus dysplasia. Neurology. 2015;84:2021–8.CrossRefPubMedPubMedCentral Harvey AS, Mandelstam SA, Maixner WJ, Leventer RJ, Semmelroch M, MacGregor D, et al. The surgically remediable syndrome of epilepsy associated with bottom-of-sulcus dysplasia. Neurology. 2015;84:2021–8.CrossRefPubMedPubMedCentral
9.
go back to reference Jin B, Wang J, Zhou J, Wang S, Guan Y, Chen S. A longitudinal study of surgical outcome of pharmacoresistant epilepsy caused by focal cortical dysplasia. J Neurol. 2016;263:2403–10.CrossRefPubMed Jin B, Wang J, Zhou J, Wang S, Guan Y, Chen S. A longitudinal study of surgical outcome of pharmacoresistant epilepsy caused by focal cortical dysplasia. J Neurol. 2016;263:2403–10.CrossRefPubMed
10.
go back to reference Najm IM, Tassi L, Sarnat HB, Holthausen H, Russo GL. Epilepsies associated with focal cortical dysplasias (FCDs). Acta Neuropathol. 2014;128:5–19.CrossRefPubMed Najm IM, Tassi L, Sarnat HB, Holthausen H, Russo GL. Epilepsies associated with focal cortical dysplasias (FCDs). Acta Neuropathol. 2014;128:5–19.CrossRefPubMed
11.
go back to reference Rubi S, Setoain X, Donaire A, Bargallo N, Sanmarti F, Carreno M, et al. Validation of FDG-PET/MRI coregistration in nonlesional refractory childhood epilepsy. Epilepsia. 2011;52:2216–24.CrossRefPubMed Rubi S, Setoain X, Donaire A, Bargallo N, Sanmarti F, Carreno M, et al. Validation of FDG-PET/MRI coregistration in nonlesional refractory childhood epilepsy. Epilepsia. 2011;52:2216–24.CrossRefPubMed
12.
go back to reference Salamon N, Kung J, Shaw SJ, Koo J, Koh S, Wu JY, et al. FDG-PET/MRI coregistration improves detection of cortical dysplasia in patients with epilepsy. Neurology. 2008;71:1594–601.CrossRefPubMedPubMedCentral Salamon N, Kung J, Shaw SJ, Koo J, Koh S, Wu JY, et al. FDG-PET/MRI coregistration improves detection of cortical dysplasia in patients with epilepsy. Neurology. 2008;71:1594–601.CrossRefPubMedPubMedCentral
Metadata
Title
18F-FDG PET and high-resolution MRI co-registration for pre-surgical evaluation of patients with conventional MRI-negative refractory extra-temporal lobe epilepsy
Authors
Yao Ding
Yuankai Zhu
Biao Jiang
Yongji Zhou
Bo Jin
Haifeng Hou
Shuang Wu
Junming Zhu
Zhong Irene Wang
Chong H. Wong
Meiping Ding
Hong Zhang
Shuang Wang
Mei Tian
Publication date
01-07-2018
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 9/2018
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-018-4017-0

Other articles of this Issue 9/2018

European Journal of Nuclear Medicine and Molecular Imaging 9/2018 Go to the issue